Articles |
 Page 1 of 24  |
Biopharmaceutical company discloses research data at cancer symposium.
October 25, 2004
|
Additional Panzem NCD preclinical data presented at EORTC-NCI-AACR Sym...
October 25, 2004
|
Biogen Idec licenses exclusive rights to proprietary TAP technology.
October 25, 2004
|
Data presented on 1D09C3 anticancer monoclonal antibody at conference.
October 25, 2004
|
ETAG potential reported in cancer drug development prognosis.
October 25, 2004
|
Pharma company provides clinical trial update.
October 25, 2004
|
FDA approves OraDisc A delivery system NDA for canker sores.
October 25, 2004
|
A fishy solution to animal infection fears.
October 25, 2004
|
Organization cheers CMS expansion of ICD coverage, but concerned about...
October 25, 2004
|
Time capsule containing heart therapeutic devices dedicated at Michiga...
October 25, 2004
|
Drug discovery company reports acute peripheral arterial occlusion tri...
October 25, 2004
|
License agreement signed with HaptoGuard Inc. for BXT-51072.
October 25, 2004
|
Life sciences company completes financing.
October 25, 2004
|
Researchers report preliminary results with percutaneous mitral valve ...
October 25, 2004
|
Web site exposes connection between inflammation and coronary heart di...
October 25, 2004
|
Company highlights activities at TCT 2004.
October 25, 2004
|
Hospice provider announces grant to launch quality initiative.
October 25, 2004
|
First patient enrolled in surveillance study of carotid artery stentin...
October 25, 2004
|
Pharma company announces results of Huntington disease trial.
October 25, 2004
|
Cholesterol-lowering chewable product with plant stanol esters introdu...
October 25, 2004
|
Biopharmaceutical company updates clinical development.
October 25, 2004
|
Data management solution provider partners with research institute.
October 25, 2004
|
Pharma research company and U.S. Wellness unite to deliver patient rec...
October 25, 2004
|
Report shows pharma companies use Web to fill clinical trial recruitme...
October 25, 2004
|
Oncology-focused drug company initiates two new clinical trials.
October 25, 2004
|
Device firm enters China market through agreement with Dalian Orientec...
October 25, 2004
|
Study questions link between SV40 and pleural mesothelioma.
October 25, 2004
|
U.K. cancer research center selects data management software for drug ...
October 25, 2004
|
Alliance to develop antibody-based therapeutics for vascular indicatio...
October 25, 2004
|
Boehringer Ingelheim to deploy DecisionSite software.
October 25, 2004
|
CombinatoRx and partner initiate brain cancer collaboration.
October 25, 2004
|
Companies to develop of Genelabs' hepatitis C compounds.
October 25, 2004
|
Deal signed for research projects in RNA expression analysis.
October 25, 2004
|
Genomics company signs agreement with Genentech for cancer research.
October 25, 2004
|
License agreement for drug eluting stents restructured.
October 25, 2004
|
Licensing deal signed with Vernalis for anticancer program.
October 25, 2004
|
Pandemic influenza vaccine agreement signed.
October 25, 2004
|
Study to employ PhosphoScan platform for kinase phosphoproteomics anal...
October 25, 2004
|
Three-year dual source agreement signed for IV Smart Pump, Smart Syste...
October 25, 2004
|
Worldwide distribution agreement signed for heart-lung machine.
October 25, 2004
|
Biotechnology company presents data on anticancer effects of cytotoxic...
October 25, 2004
|
HalfLytely and Bisacodyl Tablets Bowel Prep Kit available for colonosc...
October 25, 2004
|
TV company, natural products group join to launch goat weed aphrodisia...
October 25, 2004
|
Generic Tri-Norinyl-28 oral contraceptive tablets approved.
October 25, 2004
|
ParaGard offers safe, effective alternative to hormonal birth control.
October 25, 2004
|
Aerosol nitroglycerin lingual spray NDA accepted by FDA.
October 25, 2004
|
Preliminary results presented from COSTAR I drug-eluting stent trial.
October 25, 2004
|
Positive 6-month results reported for SPIRIT FIRST trial.
October 25, 2004
|
ANTEGREN MAA submitted to European Medicines Agency for Crohn disease.
October 25, 2004
|
Drug delivery company signs licensing agreement for Cystic Fibrosis tr...
October 25, 2004
|
Pharma company announces results from phase II trial of Bronchitol.
October 25, 2004
|
New canker sore treatment heals sores in 1-4 days.
October 25, 2004
|
New dental laser - Waterlase MD - launched at ADA meeting.
October 25, 2004
|
PCPs', psychiatrists' views examined on antidepressants and suicidal t...
October 25, 2004
|
Actinic keratosis and basal cell carcinoma treatment approved Europe.
October 25, 2004
|
Research and advisory firm forecasts that the psoriasis drug market wi...
October 25, 2004
|
Research released on HPV infection treatment.
October 25, 2004
|
Voluntary recall underway for cochlear implants.
October 25, 2004
|
CryoPlasty therapy may help people with blocked arteries avoid knee am...
October 25, 2004
|
Nutritional supplement may help hangovers, ward off alcoholism.
October 25, 2004
|
New food intolerance, complex carbohydrate intolerance, identified.
October 25, 2004
|
Cancer patients suffer anemia needlessly.
October 25, 2004
|
Preliminary results announced from carotid artery stenting study.
October 25, 2004
|
Company announces extension of negotiations for HHS anthrax contract a...
October 25, 2004
|
Pharma company issues statement on withdraw of Vioxx.
October 25, 2004
|
Topical anti-arthritic safer than pills with same active ingredient, s...
October 25, 2004
|
Application filed with U.S. FDA for childhood asthma incentive spacer.
October 25, 2004
|
Positive interim results reported from CART-2 study of anti-inflammato...
October 25, 2004
|
Oral RSD1235 patient dosing initiated in phase I study.
October 25, 2004
|
Deloitte taps skin-care company as fastest growing San Diego County te...
October 25, 2004
|
Gene-focused company ranked 24th on Deloitte's Fast 50 List in Japan.
October 25, 2004
|
Missouri State Speaker of the House named BIO State Legislator of the ...
October 25, 2004
|
Pfizer receives Microsoft Pharmaceutical Innovation Award.
October 25, 2004
|
Vikram Sheel Kumar, Dimagi president, CEO receives MIT technology huma...
October 25, 2004
|
Pharmaceutical company launches ciprofloxacin tablets.
October 25, 2004
|
| |
1
